CytomX's stock rockets after expanding Bristol-Myers collaboration [MarketWatch]
CytomX Therapeutics, Inc. (CTMX)
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.cytomx.com
Company Research
Source: MarketWatch
CytomX's stock rockets after expanding Bristol-Myers collaboration CytomX Therapeutics Inc.'s stock CTMX, +1.20% rocketed 25% toward a 14-month high in premarket trade Monday, after the company said it would receive a $200 million upfront payment from Bristol-Myers Squibb Co. BMY, -1.78% as part of the expansion of a collaboration pact to discover cancer treatments using CytomX's Probody platform. CytomX will also be eligible to receive up to $448 million in milestone payments, as well as royalty payments, if development, regulatory and sales targets are met. "CytomX's Probody platform has enhanced our discovery research as we seek to direct the therapeutic effects of immunotherapy in a more targeted approach against tumors," said Bristol-Myers Head of Discovery Carl Decicco. CytomX's stock had climbed 32% over the past three months through Friday, while Bristol-Myers shares had lost 4.8% and the S&P 500 SPX, -0.13% had gained 4.7%.
Show less
Read more
Impact Snapshot
Event Time:
CTMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTMX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTMX alerts
High impacting CytomX Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CTMX
News
- CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors [Yahoo! Finance]Yahoo! Finance
- CytomX Therapeutics Appoints Dr. Zhen Su to Board of DirectorsGlobeNewswire
- CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas [Yahoo! Finance]Yahoo! Finance
- CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with AstellasGlobeNewswire
- CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
CTMX
Earnings
- 11/7/23 - Beat
CTMX
Sec Filings
- 3/25/24 - Form PRE
- 3/22/24 - Form 4
- 3/22/24 - Form 3
- CTMX's page on the SEC website